Skyepharma is an expert CDMO specializing in formulating, developing and producing complex oral dosage forms with complex and tailor-made modified release profiles, offering a full range of services from early-stage development to industrial manufacturing and packaging. Its scientific expert team, supported by patented technologies, has a solid track record of successful development, reformulation and transfer projects, operating from an FDA-approved GMP site in France serving customers worldwide with a recognized high level of service.

No comments available.
Leave your rating & comment